Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPIRUBICIN vs EPOPROSTENOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPIRUBICIN vs EPOPROSTENOL: Safety Overview

Metric EPIRUBICIN EPOPROSTENOL
Total FAERS Reports 16,274 13,322
Deaths Reported 2,212 2,713
Death Rate 13.6% 20.4%
Hospitalizations 5,603 8,838
Average Patient Age 52.8 yrs 49.9 yrs
% Female Patients 86.1% 78.1%
FDA Approval Date Apr 15, 2011 Apr 23, 2008
Manufacturer Pharmacia & Upjohn Company LLC Mylan Institutional LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued